AIDS Malignancy Program

The AIDS Malignancy Program supports pre-clinical and clinical studies for the treatment of cancer in HIV+ and immunocompromised patients. The AMP also supports resources for preclinical and translational/interdisciplinary studies including a tissue repository of well characterized specimens collected from HIV+ and HIV- patients, and infrastructure at institutions that receive significant AIDS funding.

For more information contact the Office of HIV and AIDS Malignancy (OHAM).